Our analysis showed that cells isolated from the muscles of FSHD patients were phenotypically different from control cells (Fig. 1E) based on the distinct expression of CD90, CD73, CD140a and CD201 (Fig. 1F). This evidence concerns the gene NT5E and facioscapulohumeral muscular dystrophy.